Your browser doesn't support javascript.
loading
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization.
Fintzi, Jonathan; Bonnett, Tyler; Sweeney, Daniel A; Huprikar, Nikhil A; Ganesan, Anuradha; Frank, Maria G; McLellan, Susan L F; Dodd, Lori E; Tebas, Pablo; Mehta, Aneesh K.
Afiliação
  • Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
  • Bonnett T; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Sweeney DA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Huprikar NA; Pulmonary and Critical Care Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Ganesan A; Walter Reed National Military Medical Center, Infectious Disease Clinical Research Program, Department of Preventative Medicine and Biostatistics, Uniformed Services University of Health Sciences, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Frank MG; Department of Medicine, Denver Health Hospital Authority, Associate Professor of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • McLellan SLF; Division of Infectious Disease, University of Texas Medical Branch, Galveston, Texas, USA.
  • Dodd LE; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
  • Tebas P; Division of Infectious Diseases/Clinical Trials Unit, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Mehta AK; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Clin Infect Dis ; 74(12): 2209-2217, 2022 07 06.
Article em En | MEDLINE | ID: mdl-34409989

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos